Article Details
Retrieved on: 2024-07-04 12:49:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Merck has partnered with South Africa-based Afrigen Biologics, to support the development of an mRNA vaccine technology platform.
Article found on: www.worldpharmaceuticals.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here